The quest for a single-pill once-a-day treatment for HIV became a reality when the FDA approved Atripla on July 12. It combines the already approved drugs efavirenz (Sustiva), tenofovir (Viread), and ...

A global study led by researchers at University College London (UCL), published today in The New England Journal of Medicine, found that a regimen based on a once-a-day small dolutegravir tablet was ...

Please provide your email address to receive an email when new articles are posted on . For the first time, adolescents with HIV have the option of a two-drug, single-tablet oral treatment regimen.

The Food and Drug Administration approved a new daily drug that delivers four different HIV medications in one dose. The pill combines four HIV drugs: elvitegravir, cobicistat, emtricitabine, and ...

A daily preventive pill can be invaluable for people at risk for HIV. But some doctors don't know much about prescribing them. And billing headaches are common. Here's how to overcome those hurdles.

WHO’s 2025 HIV clinical guidelines simplify and strengthen care by recommending more durable, safer treatment regimens, ...

British pharma giant GSK on Wednesday announced promising results for a long-acting injectable HIV therapy, offering a hopeful alternative for people who take daily pills to halt the virus’s ...

Gilead Sciences’ pre-exposure prophylaxis (PrEP) formula of lenacapavir has been approved in the UK as a preventative option ...

Gilead Sciences said on Monday its experimental HIV treatment was found to be statistically non-inferior to its top-selling ...

Knowable Magazine reports on breakthroughs in HIV treatment; engineered antibodies show promise for long-term control, ...

HUNTSVILLE, AL (WAFF) - Sept. 18 marks National HIV/AIDS and Aging Awareness Day. Older Americans are more likely than younger Americans to be diagnosed with HIV infection late in the course of their ...